Skip to main content
Livermore
Livermore
ZHEN

MAI Capital Management

SEC CIK
0001040197
Latest filing
Aug 14, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by MAI Capital Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
26,116
Value
$2.36M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by MAI Capital Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,116$2.36M<0.1%−62,364−70.5%ReducedHolders
Q1 202688,480$7.09M<0.1%+532+0.6%AddedHolders
Q4 202587,948$7.50M<0.1%−1,369−1.5%ReducedHolders
Q3 202589,317$6.95M<0.1%+2,783+3.2%AddedHolders
Q2 202586,534$6.77M<0.1%+607+0.7%AddedHolders
Q1 202585,927$6.23M<0.1%+21,192+32.7%AddedHolders
Q4 202464,735$4.79M<0.1%+1,127+1.8%AddedHolders
Q3 202463,608$4.20M<0.1%+152+0.2%AddedHolders
Q2 202463,456$5.86M0.1%+1,463+2.4%AddedHolders
Q1 202461,993$5.92M0.1%+1,610+2.7%AddedHolders
Q4 202360,383$4.60M0.1%+49,772+469.1%AddedHolders
Q3 202310,611$735.1K<0.1%+351+3.4%AddedHolders
Q2 202310,260$967.8K<0.1%−503−4.7%ReducedHolders
Q1 202310,763$890.4K<0.1%+1,586+17.3%AddedHolders
Q4 20229,177$684.7K<0.1%−164−1.8%ReducedHolders
Q3 20229,341$772.0K<0.1%−1,272−12.0%ReducedHolders
Q2 202210,613$1.01M<0.1%+963+10.0%AddedHolders
Q1 20229,650$1.14M<0.1%+654+7.3%AddedHolders
Q4 20218,996$1.17M<0.1%+5,268+141.3%AddedHolders
Q3 20213,728$422.0K<0.1%+756+25.4%AddedHolders
Q2 20212,972$308.0K<0.1%+86+3.0%AddedHolders
Q1 20212,886$241.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.